Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "Chronic-Obstructive-Pulmonary-Disease"

75 News Found

Alkem to spread awareness through “The Healthy Lungs”
Healthcare | September 26, 2022

Alkem to spread awareness through “The Healthy Lungs”

Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body


Aptar Pharma collaborates with Fluidda
News | September 25, 2022

Aptar Pharma collaborates with Fluidda

The companies will leverage their respective proprietary technology platforms


Lupin receives UK MHRA Approval of Lutio for treatment of COPD
Drug Approval | August 27, 2022

Lupin receives UK MHRA Approval of Lutio for treatment of COPD

Lutio has the potential to offer significant cost savings when available to UK patients.


Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Drug Approval | July 05, 2022

Sanofi flu vaccines licensed and approved for 2022-2023 influenza season

Sanofi will begin to ship their vaccines helping to ensure more people will be immunized


Lonza to expand inhalation capabilities at Tampa site
Biotech | May 24, 2022

Lonza to expand inhalation capabilities at Tampa site

Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers


Alembic Pharmaceuticals receives USFDA  approval for Arformoterol Tartrate
Drug Approval | May 11, 2022

Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies


Alkem launches Innohaler for asthma & COPD patients
Drug Approval | May 04, 2022

Alkem launches Innohaler for asthma & COPD patients

With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes


GSK launches once daily, single inhaler-triple therapy for COPD patients
Drug Approval | April 26, 2022

GSK launches once daily, single inhaler-triple therapy for COPD patients

Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers


Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
Sustainability | April 11, 2022

Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming

Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products


Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients
Hospitals | March 31, 2022

Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients

Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India